obesity and glp 1 Battle for Obesity: the rise (and fall?) of GLP-1s Optimizing GLP-1 therapies for obesity
Description
Mounjaro hit $23 billion, and Zepbound added $13.5 billion
Discover what clinical evidence reveals about GLP-1 receptor agonists and thyroid cancer risk, who should exercise caution, and essential safety guidance for UK patients.
If youre looking into GLP-1 medications for weight loss, youve probably come across two big names: semaglutide and tirzepatide. So whats the difference
November 1, 2023
